Dr John R Prowle, MA MB BChir MSc MD FHEA FRCP FFICM
Clinical Reader in Critical Care Nephrology
Centre: Critical Care and Perioperative Medicine Research Group
Email: j.prowle@qmul.ac.ukTelephone: +44(0) 20 3594 0322
Profile
ORCID iD: 0000-0002-5002-2721
Dr Prowle is Clinical reader in Critical Care Nephrology in the Critical Care and Perioperative Medicine Research Group at William Harvey Research Institute, Queen Mary University of London and is an Honorary Consultant Physician in Intensive Care Medicine and Renal Medicine at the Royal London Hospital, Barts Health NHS Trust.
Dr Prowle graduated with distinction in medicine from the University of Cambridge in 1999 and undertook Doctoral Research under the supervision of Prof Rinaldo Bellomo (the most published and highly cited researcher in the history of Australian Medicine) in Melbourne, Australia leading to the award of his MD research doctorate in 2012.
His research interests include the pathogenesis, diagnosis and outcomes of Acute Kidney Injury, Renal replacement Therapy in the ICU the Epidemiology of Critical Illness and its recovery and the impact of multi-morbidity of high risk surgical and ICU outcomes. Since 2009 he has co-authored over 160 peer-reviewed publications and 30 book chapters.
He is a active senior contributor to national and international collaborations in critical care nephrology including the Acute Disease Quality Initiative (ADQI), Kidney Disease Improving Global Outcomes AKI Group and the UK Kidney research Consortium Clinical Studies Group in AKI (as co-chair).
Research
Critical Care and Perioperative Medicine Research Group
Dr Prowle’s academic interests include the Pathogenesis, Diagnosis and Treatment and Outcomes of Acute Kidney Injury, Continuous Renal Replacement Therapies in the ICU, Fluid Therapy and Medical Complications of Major Surgery.
Publications
-
Vickery NJ, Fowler AJ, Prowle J et al. (2025). Association between multimorbidity and quality of life after hip replacement surgery: analysis of routinely collected patient-reported outcomes. nameOfConference
-
Murugan R, Prowle J, Beaubien-Souligny W (2024). Protocolized fluid balance neutralization during continuous renal replacement therapy. nameOfConference
-
Haines RW, Granholm A, Puthucheary Z et al. (2024). The effect of high protein dosing in critically ill patients: an exploratory, secondary Bayesian analyses of the EFFORT Protein trial. nameOfConference
-
Azzopardi G, Mekhaimar A, Haines RW et al. (2025). Clinician assessment of kidney function from plasma creatinine values during critical illness: A scenario-based international multi-professional survey. nameOfConference
-
Zarbock A, Forni LG, Koyner JL et al. (2024). Recommendations for clinical trial design in acute kidney injury from the 31st acute disease quality initiative consensus conference. A consensus statement. nameOfConference
-
Kellum JA, Bagshaw SM, Demirjian S et al. (2024). CCL14 testing to guide clinical practice in patients with AKI: Results from an international expert panel. nameOfConference
-
Koyner JL, Arndt C, de Irujo JBM et al. (2024). Assessing the role of Chemokine (C–C motif) ligand 14 in AKI: a European consensus meeting. nameOfConference
-
Bellomo R, Ankawi G, Bagshaw SM et al. (2024). Hemoadsorption: consensus report of the 30th Acute Disease Quality Initiative workgroup. nameOfConference
DOI: 10.1093/ndt/gfae089
-
Davies TW, Watson N, Pilkington JJ et al. (2024). Creatine supplementation for optimization of physical function in the patient at risk of functional disability: A systematic review and meta‐analysis. nameOfConference
DOI: 10.1002/jpen.2607
Collaborators
Internal